8-K
Current Report
Atea Pharmaceuticals, Inc. Filed Acc 0001193125-21-167921
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d185451d8k.htm…